Discover near-complete TTR stabilization | Attruby® (acoramidis)
Discover near-complete TTR stabilization | Attruby® (acoramidis)
7 months ago
linkedin.com
ATTR-CM Hospitalization Consequences | Attruby® (acoramidis)
ATTR-CM Hospitalization Consequences | Attruby® (acoram…
6 months ago
linkedin.com
The News That Could Stoke BridgeBio, Up 80% This Year
The News That Could Stoke BridgeBio, Up 80% This Year
5 months ago
investors.com
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. Please see Important Safety Information at Attruby.com/#ISI for Attruby® (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. | Morgan Freeman
2:09
Learn more about how Attruby can help adults with ATTR-cardiac am…
23.3K views5 months ago
FacebookMorgan Freeman
Acoramidis: A Potential Breakthrough Treatment for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Cardiology
Acoramidis: A Potential Breakthrough Treatment for Trans…
Jul 18, 2023
labroots.com
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the First Near Complete TTR Stabilizer (=90%), Approved by the European Commission to Treat ATTR-CM
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the Fir…
4 months ago
finanznachrichten.de
Please see Important Safety Information at Attruby.com/#ISI for Attruby® (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. | Morgan Freeman
0:51
Please see Important Safety Information at Attruby.com/#ISI fo…
30.3K views5 months ago
FacebookMorgan Freeman
Impact of Attruby on serum TTR levels
4 months ago
linkedin.com
0:59
Please see Important Safety Information at Attruby.com/#ISI fo…
57.4K views10 months ago
FacebookMorgan Freeman
0:40
New Breakthrough in Heart Failure Treatment: Acoramidis for ATTR-CM
1.6K viewsDec 5, 2024
YouTubeMUSC Health
BridgeBio Pharma May Keep Outperforming as Attruby Sales B…
8 months ago
marketscreener.com
BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Im…
11 months ago
finanznachrichten.de
BridgeBio Pharma: ATTRibute-CM Study Fails To Meet Primary Endp…
Dec 27, 2021
nasdaq.com
Attruby TV Spot, 'A Diagnosis Doesn't Define You' Featuring Mor…
11 months ago
iSpot.tv
BridgeBio Pharma : des données prometteuses sur l'acoramidis da…
4 months ago
zonebourse.com
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress…
Jan 13, 2025
finanznachrichten.de
45:16
Academia + Industry with BridgeBio's Dr. Michael Henderson
583 viewsJun 21, 2021
YouTubeLife Science Connect
LLNL and BridgeBio announce trials for supercomputing-discovered ca…
5 months ago
llnl.gov
3:29
Lawrence Livermore National Lab on Instagram: "In a milestone for s…
5K viewsJun 6, 2024
Instagramlivermore_lab
Early Diagnosis of Transthyretin Amyloid Cardiomyopathy
7 months ago
medscape.com
4:51
ATTRUBY - FDA NDA approval - 2024-11-22
219 viewsDec 11, 2024
YouTubeInside Drug Discovery
1:01
Learn more about how Attruby can help adults with ATTR-cardiac am…
83 views4 months ago
YouTubeMorgan Freeman
19:42
罕見疾病新星爆發！BridgeBio (BBIO) 三大新藥報捷，單挑輝瑞巨頭，20…
18 views4 weeks ago
YouTube來聽美股吧
BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by A…
3 weeks ago
YahooMaham Fatima
BridgeBio Pharma, Inc. annonce l'approbation par la FDA de la dem…
Jan 3, 2024
zonebourse.com
BridgeBio LLC
Nov 30, 2017
biospace.com
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
138 views8 months ago
YouTubeMelissa Bime
BridgeBio Oncology Therapeutics Rings the Closing Bell
5 months ago
nasdaq.com
2:08
MAJOR BREAKOUT : BBIO STOCK ANALYSIS | BRIDGEBIO PHARM…
41 views2 months ago
YouTubeSATYAJIT DASGUPTA
8:32
Putting Patients First: BridgeBio Founder & CEO, Neil Kumar, Ph.D…
758 views10 months ago
YouTubeBridgeBio
See more videos
Static thumbnail place holder